Akina Inc. helps the medicine go down.
Frosta® – the company’s low cost, simple and reliable method for making
fast-melting tablets – makes swallowing pills much easier, especially for the
elderly, children and people on the go who don’t have an available drink.
Frosta® formulated tablets melt almost instantaneously to behave like a
liquid formulation. The Frosta® formulation has been used to develop taste-
masked cetirizine allergy tablets, 12-hour release dextromethorphan cough
tablets, and taste-masked 500 mg acetaminophen tablets. The special
Frosta® processing technology allows for the formulation of sustained release
as well as large dose drugs.
The Frosta® technology also has been used to develop nutritional
formulations, such as glucose, calcium supplements and vitamins. Recently,
the technology was applied to develop toothpaste tablets, providing relief for
In addition to Frosta®, Akina offers other drug delivery technologies, such as
Polyshell™ for long-term protein delivery, HytroCelle™ for delivery of poorly
soluble drugs, and Stentrix® for multi-drug release from drug-eluting stents. Akina’s
Aquagel® superporous hydrogel has been used in a variety of pharmaceutical and
biomedical devices, and is being developed for diet control applications.
ESTABLISHED: 2001 – Founded by Kinam Park, Ph.D., Purdue University
Professor of Biomedical Engineering and Pharmaceutics
KEY PERSONNEL: Kinam Park, President; Haesun Park, VP; Yourong Fu,
FUNDING: Research Grants
CONTACT: Purdue Research Park , Business & Technology Center,
1291 Cumberland Ave., West Lafayette, IN, 47906; (765)